Floatz logo

Tiotropium

Chronic Obstructive Pulmonary Disease

Henan University of Traditional Chinese MedicineSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

22 Active assets in the Chronic Obstructive Pulmonary Disease cohort.

Asset / SponsorPhaseRating
Liraglutide
Claus Bogh Juhl
Phase 4BB
Roflumilast
Prince of Songkla University
Phase 3BB
Ciprofloxacin
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Phase 4BB
Piperacillin
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Phase 4BB
.ALPHA.-1 PROTEASE INHIBITOR
Takeda
Phase 4BB

View all 50 →

Same molecule, other indications

Tiotropium is also rated in:

cystic fibrosisDormant
BB
Indicative ·
66 / 100
View asset →
non-small cell lung carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
asthmaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →